Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Pesticide sales in Europe and the Americas declined due to weather conditions and competition from generic products, among other factors. Operating profit decreased due to higher research and development expenses. The interim net loss attributable to owners of the parent was affected by the impairment loss related to 富士チタン工業 Co., Ltd.'s withdrawal from its business and the increased temporary reversal of deferred tax assets as a reaction to the strong performance in the previous fiscal year.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | ¥73,571 million (YoY -3.8%) |
| Operating profit | ¥3,080 million (YoY -58.2%) |
| Ordinary income | ¥3,854 million (YoY -54.7%) |
| Profit attributable to owners of the parent | ¥-999 million |
| Net income per share | △¥26.09 |
| Equity ratio | End of the current fiscal period 53.5 / End of previous period 53.7 |
| Total assets | ¥234,418 million |
| Net assets | ¥125,748 million |
| Cash flows from operating activities | ¥21,507 million |
| Cash flows from investing activities | ¥-1,229 million |
| Cash flows from financing activities | ¥-9,502 million |
| Cash and cash equivalents at end of period | ¥40,356 million |
| Full-year earnings forecast | Net Sales ¥151,000 million (YoY -2.5%) / Operating profit ¥15,800 million (YoY -17.2%) / Ordinary income ¥15,600 million (YoY -28.2%) / Net income ¥7,100 million (YoY -57.3%) |
| Revision to Earnings Forecast | Not disclosed → Net Sales ¥151,000 million / Operating profit ¥15,800 million / Ordinary income ¥15,600 million / Net income ¥7,100 million |
| Annual Dividend Forecast | ¥120 → ¥130（+8.3%） |
| Segment revenue | Organic chemicals business ¥37,966 million / Inorganic Chemicals Business ¥33,639 million / Other Businesses ¥1,965 million |
| Segment profit | Organic chemicals business ¥1,841 million / Inorganic Chemicals Business ¥3,678 million / Other Businesses ¥78 million |
| Regional sales | Japan ¥29,431 million / Asia ¥14,243 million / Americas ¥9,706 million / Europe ¥19,405 million / Other ¥784 million |
| Depreciation and amortization | ¥2,551 million |
| Impairment loss | ¥2,649 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥193 million, Gain on sale of investment securities ¥102 million, Insurance proceeds received ¥124 million / Extraordinary loss Impairment loss ¥2,649 million, Loss on disposal of fixed assets ¥279 million, Business Exit Losses ¥163 million, Loss on closure of a plant ¥144 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes (not stated on the cover) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for analysts) |
| Issued Shares at Period-End | 40,383,943 |
| Treasury Shares at Period-End | 2,033,869 |
| Factors Behind Changes in Business Performance | Pesticide sales in Europe and the Americas declined due to weather conditions and competition from generic products, among other factors. Operating profit decreased due to higher research and development expenses. The interim net loss attributable to owners of the parent was affected by the impairment loss related to 富士チタン工業 Co., Ltd.'s withdrawal from its business and the increased temporary reversal of deferred tax assets as a reaction to the strong performance in the previous fiscal year. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Pesticide sales in Europe and the Americas declined due to weather conditions and competition from generic products, among other factors; research and development expenses increased; an impairment loss was recognized in connection with the decision by 富士チタン工業 Co., Ltd. to withdraw from its business; and the reversal of deferred tax assets increased temporarily as a reaction to the strong performance in the previous fiscal year.